China Biopharma Company Profile

17:32 EDT 18th March 2018 | BioPortfolio

China Biopharma Inc. (Stock Symbol: CBPC.OB) is a fast growing provider of human vaccine products in China. Through its wholly owned subsidiary, China Biopharma Limited, the Company owns the majority interest of Zhejiang Tianyuan Biotech Co., Ltd. The Company's current products consist of human vaccines against influenza (flu), epidemic hemorrhagic fever (HF), and Japanese Encephalitis (JE). With its investment and ownership of local Chinese bio-pharmaceutical companies, the Company plans to build a leading bio-pharmaceutical company in China by leveraging its manufacturing and marketing capabilities and introducing advanced technologies, best products, and experienced management teams. With a fast growing market, newly completed production facilities, and several other new vaccines in the pipeline, the Company expects to see steady business growth in the near future.


31 Airpark Road
United States of America


Phone: 609-651-8588
Fax: 609-228-4301

News Articles [4122 Associated News Articles listed on BioPortfolio]

Loncar Investment Starts China Biopharma Stock Index

Loncar Investments has launched its Loncar China Biopharma Index (LCHINA), an index comprised of 32 China publicly traded biotech companies. The index, which is re-priced once a day, includes innovati...

I-Mab Biopharma buys rights to HyLeukin

In a second significant in-licensing deal this month, Shanghai, China-based I-Mab Biopharma receives…

The Latest on China

China’s impact on biopharma has been a perennial story in the press (and on this blog). The big picture has been the interplay between the “China as a source of cheap scientific laborR...

I-Mab Biopharma gets rights to myeloma drug for China in up to $120 million deal

MorphoSys has entered into an agreement with Shanghai-based I-Mab Biopharma granting the latter an exclusive…

United Biopharma expands in China with a MAb facility in Yangzhou

Taipei, Taiwan-based United Biopharma (UBP) partnered with GE Healthcare Life Sciences to build a biologics…

China’s Emergence Into the Global Pharma Industry

Recently big pharma have been taking advantage of the financial and industrial environment in China. In this interview Fintan Walton and Dr. Bill Guo, founder and Chairman of Venturepharm, take a look...

Third Venture and Tasgen merge to form I-MAB

Third Venture Biopharma and Tasgen Bio-Tech Co. Ltd. have merged to form a new firm called I-MAB Biopharma, which will focus on development in China of biologics for cancer and autoimmune diseases.

New facility for biopharmaceutical manufacturing in China

United BioPharma plans to build a state-of-the-art manufacturing plant to support the expanding monoclonal antibody drugs market in China

PubMed Articles [983 Associated PubMed Articles listed on BioPortfolio]

The Influence of Different Caregivers on Infant Growth and Development in China.

An increasing number of parents in China ask grandparents or babysitters to care for their children. Modern parents are often the only child in their family because of China's One-Child Policy and thu...

HIV epidemics in Shenzhen and Chongqing, China.

Men who have sex with men (MSM) and heterosexuals are the populations with the fastest growing HIV infection rates in China. We characterize the epidemic growth and age patterns between these two rout...

Electronic cigarette use and smoking cessation behavior among adolescents in China.

China produces the majority of the world's electronic cigarettes (e-cigarettes) and e-cigarettes have become popular in the country, especially among young people. However, little is known about the c...

Moving towards a better path? A mixed-method examination of China's reforms to remedy medical corruption from pharmaceutical firms.

Few studies have systematically examined the effects of the existing regulations for alleviating corruption in China. This study assesses the effectiveness of China's reforms to curb medical corruptio...

Vehicle exhaust: An overstated cause of haze in China.

Overall, total exhaust emissions of NOX, VOC and particulate matter (PM) declined, though vehicles in use continued to increase in China. This suggested that contribution of motor vehicle exhaust to h...

Clinical Trials [727 Associated Clinical Trials listed on BioPortfolio]

SYNERGY China: Assess SYNERGY Stent in China

Prospective, multicenter, single-arm study, enroll 100 patients in no more than 10 sites across China, the primary endpoint is Technical success.

China PEACE Millions Persons Project

China PEACE Millions Persons Project is a national screening project for cardiovascular disease in China. This Project was approved by National Health and Family Planning Commission (NHFPC...

Study of China Heart Failure Registry to Investigate Characteristics of Patients in China

The purpose of this study is to assess clinical characteristics, treatment, and outcome of patients hospitalized with heart failure in China and compared those with other registries

Primary and Secondary Prevention of Human Papillomavirus (HPV) Disease in China

In a hospital-based multi-center study in China, HPV 16 was found to be the predominant type (72.9%) in cervical cancer, followed by HPV 18(8.0%) which indicated that if the HPV prophylact...

HIV Assessment in Fuyang, Anhui Province, China

The purpose of this study was to examine the needs, concerns, stigmas, and social networks of HIV infected former plasma donors (FPDs) and their relatives in Fuyang, Anhui Province, China....

Companies [640 Associated Companies listed on BioPortfolio]

China Biopharma

China Biopharma Inc. (Stock Symbol: CBPC.OB) is a fast growing provider of human vaccine products in China. Through its wholly owned subsidiary, China Biopharma Limited, the Company owns the majority ...

SAFE-BioPharma Association

SAFE-BioPharma Association ( is the non-profit association that created and manages the SAFE-BioPharma® digital identity and signature standard for the ...

Genesis Biopharma, Inc.

Genesis Biopharma, Inc. is a development-stage biotechnology company engaged primarily in the development of targeted cancer therapies. For more information on the Company, visit http://www.genesis-b...

TenX Biopharma, Inc.

TenX Biopharma, Inc., is a biopharmaceutical company focused on late stage development and commercialization of novel monoclonal antibody-based cancer therapies. TenX Biopharma acquired global rights ...

Rentschler Biopharma SE

Rentschler Biopharma SE, located in Laupheim, Germany, is a leading contract development and manufacturing organization (CDMO) for bioprocess development and manufacturing of biop...

More Information about "China Biopharma" on BioPortfolio

We have published hundreds of China Biopharma news stories on BioPortfolio along with dozens of China Biopharma Clinical Trials and PubMed Articles about China Biopharma for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of China Biopharma Companies in our database. You can also find out about relevant China Biopharma Drugs and Medications on this site too.

Quick Search


Relevant Topic

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Corporate Database Quicklinks

Searches Linking to this Company Record